David J. Friedman

Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40

David J. Messenheimer, Shawn M. Jensen, Michael Afentoulis et al. · Clinical Cancer Research · 2017 · 310 citations · Full text

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy

Kristina H. Young, Jason R. Baird, Talicia Savage et al. · PLoS ONE · 2016 · 308 citations · Full text

Immunology, Ideal Timing, Immunotherapy +17

p21 produces a bioactive secretome that places stressed cells under immunosurveillance

Ines Sturmlechner, Cheng Zhang, Chance Sine et al. · Science · 2021 · 242 citations · Full text

Protein Secretion, Immunology, Immune Regulation +25

Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors

Jason R. Baird, David J. Friedman, Benjamin Cottam et al. · Cancer Research · 2015 · 232 citations

Immunology, Immune Regulation, Pathology +24

The 289-amino acid E1A protein of adenovirus binds zinc in a region that is important for trans-activation.

J S Culp, L C Webster, David J. Friedman et al. · Proceedings of the National Academy of Sciences · 1988 · 118 citations · Full text

Virus Structure, Viral Replication, Biochemistry +15